NONOF - NASH drug market expected to surpass $48B by 2035
2024-03-16 12:57:30 ET
More on Madrigal Pharmaceuticals
- Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge
- Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown
- Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade)
- Biggest stock movers today: RIVN, ADBE, GERN, and more
- Madrigal climbs amid hopes for new NASH drug; B. Riley upgrades